🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to understand whether participants could moun...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-04-19
Trial ID
NCT04792567
Treatments Being Tested
The primary goal of this study is to assess the impact of the two major dis...
Status
Completed
Location
Brigham MS Center
Start Date
2021-06-01
Trial ID
NCT05060354
Treatments Being Tested
This study will utilize a prospective, observational, exposure cohort desig...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2021-12-15
Trial ID
NCT04933552
Treatments Being Tested
To assess the efficacy of Mayzent on microglia pathology in patients with a...
Status
Terminated
Location
University at Buffalo, Buffalo General Hospital
Start Date
2021-11-13
Trial ID
NCT04925557
The DELIVER-MS study seeks to answer the question: Does early treatment wit...
Status
Active Not Recruiting
Location
University of Colorado-Anschutz Medical Campus
Start Date
2019-01-03
Trial ID
NCT03535298
Treatments Being Tested
To assess safety and tolerability of patients converting from approved Rela...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-02-14
Trial ID
NCT03623243
Treatments Being Tested
Collaboration with multiple sclerosis (MS) specialty colleagues led us to f...
Status
Recruiting
Location
St. Joseph's Hospital and Medical Center
Start Date
2025-08-26
Trial ID
NCT06639282
This study was a retrospective, non-interventional, longitudinal, descripti...
Status
Completed
Location
Novartis Investigational Site
Start Date
2020-07-09
Trial ID
NCT05826028
FDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) tar...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2018-05-02
Trial ID
NCT03500328
Treatments Being Tested
This is an observational, multicenter, single-arm, prospective study conduc...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-06-17
Trial ID
NCT05376579
Treatments Being Tested